Description
Here are some of the specific uses of Artefan 18:
- Treatment of malaria
- Prevention of malaria
- Treatment of other conditions
Sh1,500.00
Artefan 18 is a medication that contains a combination of artemether and lumefantrine. It is primarily used to treat uncomplicated malaria caused by Plasmodium falciparum
Here are some of the specific uses of Artefan 18:
Settings | ARTEFAN 18 remove | Atenolol 50 Anol remove | AMBROSAN SYRUP AMBROXOL 100ML remove | Artequick Tablets remove | AMBROX DROPS 15ML remove | ACNOTIN 10MG remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh1,500.00 | Sh4,000.00 | Sh3,000.00 | Sh11,000.00 | Sh2,500.00 | Sh38,000.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | Artefan 18 is a medication that contains a combination of artemether and lumefantrine. It is primarily used to treat uncomplicated malaria caused by Plasmodium falciparum | Ambroxol drops are a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. | ||||
Content | Here are some of the specific uses of Artefan 18:
| Anol 50mg Tablet belongs to a group of medicines called beta-blockers. It is used to treat high blood pressure (hypertension), angina (heart-related chest pain), irregular heart rhythms (arrhythmia). It also helps to prevent future heart attacks and stroke and migraines. | Prescribed for various respiratory diseases such as
| Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury | The main uses of Ambroxol drops include:
| Isotretinoin Capsule belongs to a group of medicines called retinoids, which are closely related to vitamin A derivative. It is used to treat:
|
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.